Dr David Woolf is Consultant Clinical Oncologist at The Christie NHS Foundation Trust, where he plans and delivers chemotherapy, endocrine therapy and targeted drug therapy in addition to radiotherapy to patients with breast and lung cancers and Stereotactic Ablative Radiotherapy (SABR) for lung cancers and locally recurrent cancers. He has also completed training in the USA in proton beam radiotherapy.
Dr Woolf is a graduate of the University of Birmingham, undertaking his Core medical and Clinical Oncology training in London at the University College Hospital, The Royal Free and St Bartholomew’s, in addition to a Master’s Degree in Oncology at the Institute of Cancer Research and a Doctorate of Medicine after research at Mount Vernon Cancer Centre.
Dr Woolf maintains his interest as a member of the breast and lung cancer disease orientated group at The Christie and remains up to date with the rapid ongoing changes in cancer treatment. He also is involved in the professional training of clinical oncologists nationally through the Royal College of Radiologists.
Most of his spare time is taken up with his young family but outside of this he exercises regularly and reads widely.
BMedSci (Hons) 2001 The University of Birmingham
MB ChB 2004 The University of Birmingham
MRCP (UK) 2007 The Royal College of Physicians
FRCR 2012 The Royal College of Radiologists
MSC 2012 The University of London
MD (Res) 2016 The University of London
Lung and breast cancers